{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-018902","form_type":"8-K","ticker":"VTGN","cik":"0001411685","company_name":"Vistagen Therapeutics, Inc.","filed_at":"2024-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.306442+00:00","generated_at":"2026-06-01T07:07:17.592405+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vistagen stockholders approve major increase in authorized equity shares","bullets":["Approved amendment to 2019 Omnibus Equity Incentive Plan: authorized shares increase from 1M to 5M; 82.0% votes cast in favor.","Approved amendment to 2019 Employee Stock Purchase Plan: authorized shares increase from 33,334 to 1M; 82.3% votes cast in favor.","Both proposals passed at special meeting held May 29, 2024, with over 82% of votes cast supporting each.","Total potential dilution from the two plan amendments increases available shares by 4.97M (net of prior reserves)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-018902","json":"https://secwatch.observer/filing/0001437749-24-018902.json","markdown":"https://secwatch.observer/filing/0001437749-24-018902.md","text":"https://secwatch.observer/filing/0001437749-24-018902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411685/000143774924018902/0001437749-24-018902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411685/000143774924018902/vtgn20240529_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:07:17.592405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}